| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 05/15/2013 | EP2590955A1 Spiro-cyclic amine derivatives as s1p modulators |
| 05/15/2013 | EP2590954A1 Bisaryl (thio)morpholine derivatives as s1p modulators |
| 05/15/2013 | CN101389738B Use of polynuclear phenolic compounds as stabilisers |
| 05/14/2013 | US8440854 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17 |
| 05/14/2013 | US8440837 2-substituted-ethynylthiazole derivatives and uses of same |
| 05/08/2013 | CN103097364A Spiro-Cyclic Amine Derivatives as S1P Modulators |
| 05/07/2013 | US8436130 Structured organic films having an added functionality |
| 05/07/2013 | US8435968 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 05/07/2013 | CA2514100C Carboxamide derivatives and the use thereof as factor xa inhibitors |
| 05/02/2013 | US20130109853 Preparation method of 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(s)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazole-3-one |
| 05/02/2013 | US20130109684 Grp94 inhibitors |
| 05/02/2013 | US20130109683 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace) |
| 05/02/2013 | US20130109672 Activators of human pyruvate kinase |
| 05/01/2013 | EP2585444A1 Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| 05/01/2013 | CN103080096A Bisaryl (thio)morpholine derivatives as S1P modulators |
| 05/01/2013 | CN101809005B Fused bicyclic compound |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/25/2013 | WO2013056428A1 Benzoxazine intermediate and preparation method thereof |
| 04/25/2013 | WO2013005168A3 Cannabinoid receptor modulators |
| 04/25/2013 | US20130102780 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
| 04/25/2013 | US20130102779 Substituted Tetracycline Compounds |
| 04/25/2013 | US20130102610 Phenoxy acetic acids as ppar delta activators |
| 04/25/2013 | US20130102014 Fluorinated resorufin compounds and their application |
| 04/24/2013 | EP2582667A1 Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators |
| 04/24/2013 | CN103058948A Benzoxazine resin containing Schiff base structure benzoxazine monomer and preparation thereof |
| 04/23/2013 | US8426588 Phenylalanine derivatives |
| 04/23/2013 | US8426429 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 04/23/2013 | US8426422 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/23/2013 | CA2538906C Process for preparing 4-(4-aminophenyl)-3-morpholinone |
| 04/18/2013 | WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | US20130096127 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 04/18/2013 | US20130096105 ArylSulfonamide Based Matrix Metalloprotease Inhibitors |
| 04/18/2013 | CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/17/2013 | EP2580201A2 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
| 04/17/2013 | EP2580200A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace) |
| 04/17/2013 | EP2579888A2 Novel glp-1 receptor stabilizers and modulators |
| 04/17/2013 | CN103044349A Microwave-assisted method for preparing ethylenediamine tetraacetic dianhydride by using nano-ferrite |
| 04/17/2013 | CN103044348A Benzoxazine resin containing sulfonic group, and preparation method and application thereof |
| 04/17/2013 | CN102260224B Method for synthesizing 2-morpholone derivatives |
| 04/17/2013 | CN101326161B Novel compounds |
| 04/16/2013 | US8420809 Process for the manufacturing of betamimetics |
| 04/16/2013 | US8420808 Process for the preparation of efavirenz |
| 04/11/2013 | WO2013050721A1 Compounds that trap alpha-oxoaldehydes and alpha-beta-unsaturated aldehydes, meta-compounds containing such compounds, and use of said compounds in treating illnesses related to the accumulation of ages and ales |
| 04/11/2013 | WO2013050270A1 Benzoxazine derivatives as crac modulators |
| 04/11/2013 | WO2013006098A3 2,6-diisobornylphenol derivatives |
| 04/11/2013 | US20130090333 Benzoxazine derivatives as crac modulators |
| 04/11/2013 | US20130089624 Compounds Useful as Inhibitors of ATR Kinase |
| 04/04/2013 | WO2013049719A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | WO2013049250A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
| 04/04/2013 | WO2013045411A1 Spirobifluorene compounds for light emitting devices |
| 04/04/2013 | WO2013045410A1 Spirobifluorene compounds for light emitting devices |
| 04/04/2013 | CA2850166A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
| 04/03/2013 | EP2574608A1 Spirobifluorene compounds for light emitting devices |
| 04/03/2013 | CN103025710A Process for the synthesis of isothiocyanates and derivatives thereof and uses of same |
| 04/03/2013 | CN103012841A Cardanol-aromatic diamine type benzoxazine flexibilizer as well as preparation method and purposes thereof |
| 04/03/2013 | CN103012388A Preparation methods for rivaroxaban and intermediate thereof, and intermediate compounds |
| 04/03/2013 | CN103012306A Biology base molindone polyhydric alcohol as well as preparation method and application of biology base molindone polyhydric alcohol |
| 04/03/2013 | CN103012305A Method for preparing fosaprepitant intermediate |
| 04/03/2013 | CN102093152B Method for splitting chiral medicament |
| 04/02/2013 | US8410166 Fused bicyclic compound |
| 03/28/2013 | US20130079339 Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 03/27/2013 | EP2571859A2 Hydroxybupropion analogues for treating drug dependence |
| 03/27/2013 | EP2571858A1 Phenylmorpholines and analogues thereof |
| 03/27/2013 | CN102993116A Preparation method of benzoxazine excitant |
| 03/27/2013 | CN102026989B Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 03/27/2013 | CN102020616B Method for preparing 2-(3-oxo-morpholine) acetonitrile |
| 03/21/2013 | WO2013039185A1 Benzoxazine compound and manufacturing method therefor |
| 03/21/2013 | WO2013037960A1 Ep1 receptor ligands |
| 03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
| 03/21/2013 | US20130072488 Aralkyl diamine derivatives and uses thereof as antidepressants |
| 03/21/2013 | US20130072480 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators |
| 03/21/2013 | US20130072478 N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl-amides as bace1 inhibitors |
| 03/21/2013 | CA2848786A1 Ep1 receptor ligands |
| 03/19/2013 | US8399661 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof |
| 03/19/2013 | US8399612 Asymmetric synthesis of peptides |
| 03/19/2013 | US8399459 1,4 oxazines as BACE1 and/or BACE2 inhibitors |
| 03/14/2013 | WO2013033955A1 Benzoxazine monomer comprising benzocyclobutenyl functional group, synthetic method therefor and use thereof |
| 03/14/2013 | US20130065861 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 03/13/2013 | CN1953967B Purification of progesterone receptor modulators |
| 03/13/2013 | CN101528671B MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 03/12/2013 | US8394791 Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug |
| 03/07/2013 | WO2013033245A1 Bicyclic methylene aziridines and reactions thereof |
| 03/07/2013 | US20130059853 Biaryl phosphodiesterase inhibitors |
| 03/06/2013 | EP2563761A1 Activators of human pyruvate kinase |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/06/2013 | CN102952073A Method for synthesizing dihydrogen phenanthridine |
| 03/05/2013 | US8389698 Tanaproget derivatives, metabolites, and uses thereof |
| 03/05/2013 | US8389513 2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides |
| 02/28/2013 | US20130053557 Processes for preparing linezolid |
| 02/27/2013 | EP2560964A1 Process for preparing 4-(4-aminophenyl)morpholin-3-one |
| 02/26/2013 | US8383811 Process for preparing efavirenz polymorph |
| 02/26/2013 | US8383637 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 02/21/2013 | DE102009003033B4 Polymerisierbare Benzoxazin-Verbindungen mit grenzflächenaktiven bzw. oberflächenaktiven Eigenschaften Polymerizable benzoxazine compounds with surfactants or surface-active properties |
| 02/20/2013 | EP2558437A2 Methods for producing viloxazine salts and novel polymorphs thereof |
| 02/20/2013 | CN101959427B Flavor molecules |
| 02/19/2013 | US8377931 Benzoxazine derivatives and uses thereof |
| 02/19/2013 | US8377930 PDE10 inhibitors and related compositions and methods |
| 02/14/2013 | WO2013022595A1 Method for producing benzoxazine compounds |
| 02/14/2013 | US20130041147 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters |
| 02/14/2013 | US20130040954 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |